Real-time Estimate
Cboe BZX
13:28:38 2024-05-02 EDT
|
5-day change
|
1st Jan Change
|
95.22
USD
|
+0.92%
|
|
+1.05%
|
+5.35%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
33,186
|
26,966
|
37,333
|
30,974
|
49,906
|
55,761
|
-
|
-
|
Enterprise Value (EV)
1 |
48,189
|
39,162
|
51,195
|
44,890
|
63,648
|
69,824
|
71,082
|
71,952
|
P/E ratio
|
26.8
x
|
27.7
x
|
110
x
|
219
x
|
137
x
|
73.5
x
|
56.2
x
|
49
x
|
Yield
|
4.26%
|
4.18%
|
2.84%
|
3.72%
|
2.71%
|
2.62%
|
2.77%
|
2.96%
|
Capitalization / Revenue
|
6.48
x
|
5.85
x
|
7.87
x
|
5.29
x
|
7.52
x
|
7.08
x
|
6.67
x
|
6.14
x
|
EV / Revenue
|
9.41
x
|
8.5
x
|
10.8
x
|
7.66
x
|
9.59
x
|
8.86
x
|
8.5
x
|
7.92
x
|
EV / EBITDA
|
20.9
x
|
20.8
x
|
27.8
x
|
20.9
x
|
25.3
x
|
23.9
x
|
21.5
x
|
20
x
|
EV / FCF
|
54.5
x
|
42.6
x
|
89.1
x
|
-
|
-
|
84.9
x
|
48.5
x
|
37.1
x
|
FCF Yield
|
1.83%
|
2.35%
|
1.12%
|
-
|
-
|
1.18%
|
2.06%
|
2.69%
|
Price to Book
|
2.16
x
|
1.69
x
|
2.18
x
|
1.58
x
|
2.02
x
|
2.12
x
|
1.98
x
|
2.14
x
|
Nbr of stocks (in thousands)
|
405,800
|
417,305
|
435,275
|
472,521
|
553,469
|
590,934
|
-
|
-
|
Reference price
2 |
81.78
|
64.62
|
85.77
|
65.55
|
90.17
|
94.36
|
94.36
|
94.36
|
Announcement Date
|
20-02-12
|
21-02-09
|
22-02-15
|
23-02-15
|
24-02-13
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
5,121
|
4,606
|
4,742
|
5,861
|
6,638
|
7,876
|
8,361
|
9,083
|
EBITDA
1 |
2,305
|
1,880
|
1,841
|
2,151
|
2,511
|
2,927
|
3,299
|
3,597
|
EBIT
1 |
1,278
|
841.3
|
803.3
|
841.1
|
1,110
|
1,159
|
1,537
|
1,717
|
Operating Margin
|
24.95%
|
18.27%
|
16.94%
|
14.35%
|
16.72%
|
14.71%
|
18.39%
|
18.91%
|
Earnings before Tax (EBT)
1 |
542.9
|
-31.55
|
170.8
|
173.1
|
350
|
710.6
|
1,024
|
1,334
|
Net income
1 |
1,232
|
978.8
|
336.1
|
141.2
|
340.1
|
727.3
|
939.6
|
1,068
|
Net margin
|
24.06%
|
21.25%
|
7.09%
|
2.41%
|
5.12%
|
9.23%
|
11.24%
|
11.76%
|
EPS
2 |
3.050
|
2.330
|
0.7800
|
0.3000
|
0.6600
|
1.285
|
1.678
|
1.925
|
Free Cash Flow
1 |
883.7
|
918.4
|
574.8
|
-
|
-
|
821.9
|
1,467
|
1,938
|
FCF margin
|
17.25%
|
19.94%
|
12.12%
|
-
|
-
|
10.44%
|
17.55%
|
21.33%
|
FCF Conversion (EBITDA)
|
38.34%
|
48.86%
|
31.22%
|
-
|
-
|
28.09%
|
44.47%
|
53.87%
|
FCF Conversion (Net income)
|
71.7%
|
93.83%
|
170.99%
|
-
|
-
|
113.01%
|
156.14%
|
181.37%
|
Dividend per Share
2 |
3.480
|
2.700
|
2.440
|
2.440
|
2.440
|
2.473
|
2.617
|
2.794
|
Announcement Date
|
20-02-12
|
21-02-09
|
22-02-15
|
23-02-15
|
24-02-13
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
1,240
|
1,309
|
1,396
|
1,473
|
1,474
|
1,519
|
1,561
|
1,665
|
1,662
|
1,750
|
1,860
|
1,992
|
2,065
|
2,112
|
2,131
|
EBITDA
1 |
478.1
|
491
|
504.3
|
581.9
|
526.9
|
538.4
|
558.6
|
662.5
|
620.6
|
669.4
|
709.5
|
726.7
|
761
|
783.3
|
769.4
|
EBIT
1 |
210.4
|
206.5
|
200.2
|
271.6
|
173.2
|
196.1
|
219.5
|
320.6
|
281.3
|
288.6
|
343.6
|
326
|
339.8
|
356.9
|
-
|
Operating Margin
|
16.97%
|
15.77%
|
14.35%
|
18.44%
|
11.75%
|
12.91%
|
14.06%
|
19.25%
|
16.93%
|
16.5%
|
18.48%
|
16.36%
|
16.45%
|
16.9%
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
38
|
152.3
|
72.24
|
87.46
|
140.9
|
179
|
191
|
209.5
|
221.4
|
Net income
1 |
179.7
|
58.67
|
61.92
|
89.78
|
-6.767
|
-3.728
|
25.67
|
103
|
127.5
|
83.91
|
127.1
|
178.8
|
194.2
|
206.4
|
192
|
Net margin
|
14.49%
|
4.48%
|
4.44%
|
6.1%
|
-0.46%
|
-0.25%
|
1.64%
|
6.19%
|
7.67%
|
4.8%
|
6.84%
|
8.98%
|
9.4%
|
9.77%
|
9.01%
|
EPS
2 |
0.4200
|
0.1300
|
0.1400
|
0.2000
|
-0.0100
|
-0.0100
|
0.0500
|
0.2000
|
0.2400
|
0.1500
|
0.2200
|
0.3093
|
0.3468
|
0.3640
|
0.3500
|
Dividend per Share
2 |
0.6100
|
0.6100
|
0.6100
|
0.6100
|
0.6100
|
0.6100
|
-
|
0.6100
|
0.6100
|
0.6100
|
0.6100
|
0.6117
|
0.6133
|
0.6183
|
0.6533
|
Announcement Date
|
21-11-04
|
22-02-15
|
22-05-10
|
22-08-09
|
22-11-07
|
23-02-15
|
23-05-02
|
23-07-31
|
23-10-30
|
24-02-13
|
24-04-29
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
15,003
|
12,196
|
13,862
|
13,916
|
13,742
|
14,064
|
15,321
|
16,191
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.51
x
|
6.488
x
|
7.53
x
|
6.468
x
|
5.472
x
|
4.806
x
|
4.644
x
|
4.501
x
|
Free Cash Flow
1 |
884
|
918
|
575
|
-
|
-
|
822
|
1,467
|
1,938
|
ROE (net income / shareholders' equity)
|
8.17%
|
6.21%
|
2%
|
0.74%
|
1.49%
|
2.69%
|
3.62%
|
4.28%
|
ROA (Net income/ Total Assets)
|
3.87%
|
2.97%
|
1%
|
0.39%
|
0.83%
|
1.6%
|
2.4%
|
3%
|
Assets
1 |
31,861
|
32,932
|
33,698
|
36,405
|
40,951
|
45,458
|
39,189
|
35,613
|
Book Value Per Share
2 |
37.90
|
38.30
|
39.40
|
41.40
|
44.70
|
44.60
|
47.60
|
44.10
|
Cash Flow per Share
2 |
3.800
|
3.270
|
2.990
|
2.860
|
3.090
|
3.830
|
4.550
|
5.030
|
Capex
1 |
652
|
446
|
701
|
1,108
|
1,533
|
1,323
|
1,078
|
932
|
Capex / Sales
|
12.74%
|
9.69%
|
14.77%
|
18.9%
|
23.09%
|
16.8%
|
12.89%
|
10.26%
|
Announcement Date
|
20-02-12
|
21-02-09
|
22-02-15
|
23-02-15
|
24-02-13
|
-
|
-
|
-
|
Last Close Price
94.36
USD Average target price
103.9
USD Spread / Average Target +10.16% Consensus |
1st Jan change
|
Capi.
|
---|
| +5.35% | 55.76B | | -8.91% | 17.64B | | -4.24% | 13.29B | | +1.21% | 7.58B | | -17.41% | 5.54B | | +12.87% | 3.37B | | -0.63% | 3.22B | | -2.36% | 3.05B | | -1.93% | 2.8B | | +15.29% | 2.75B |
Healthcare REITs
|